Chart, page-82

There is no reasonable valuation on emerging technologies.

BRN's base mkt cap is based upon IP. Sales only accelerates it. For a technology that in the long run could be worth hundreds of billions, with the current amount of validation proving it's the real deal, $89M ($172M fd) would be considered laughable or undervalued.

However, as a listed company, by the numbers of course BrainChip's business is overvalued. If the quarterly is eventful, we're most likely back in the trading range or possibly push through it. If it's the same old info being pushed out with no revenue, I'd agree to watch out because ST share price is going to perform bad.

When SP was 0.36 not too long ago based on no news or developments and then the disappointing quarterly was released - it was a no brainer it was going to be dumped.

We are in a very different position now. In the past 3 months, there has been major developments, key hires and one can only hope revenue has started to be lumpy. SP has already dumped before quarterly on relative low volume. We aren't at soaring highs, we are at a reasonable if not oversold SP.